DEFA14A: Amylyx Pharmaceuticals Sets Date for 2024 Annual Stockholder Meeting

Amylyx Pharmaceuticals announces its annual stockholder meeting to be held virtually on June 6, 2024, with proxy materials available online.

Summary

• Amylyx Pharmaceuticals will hold its 2024 Annual Meeting of Stockholders virtually on June 6, 2024, at 9:00 a.m. Eastern Time.
• Stockholders can access the meeting online at meetnow.global/MHTTH5N using the information printed in the shaded bar on the proxy materials.
• The meeting will include the election of directors, ratification of Deloitte & Touche LLP as the independent accounting firm, and advisory votes on executive compensation and the frequency of future compensation votes.
• The Board of Directors recommends voting FOR the listed director nominees, FOR Proposals 2 and 3, and for 1 YEAR on Proposal 4.
• Proxy materials, including the 2024 proxy statement and annual report, are available online at www.envisionreports.com/AMLX.
• Stockholders can request a paper or email copy of the proxy materials by May 27, 2024.
• Voting can be done online or by requesting a proxy card with the paper materials.

Sentiment

Score: 7

Explanation: The document is a neutral announcement of a routine corporate event. It provides necessary information for shareholders to participate in the annual meeting.

Positives

• The meeting is being held virtually, providing convenient access for stockholders.
• Stockholders have multiple options for accessing proxy materials and voting, including online and by mail.
• The Board of Directors has provided clear recommendations on how to vote on each proposal.

Future Outlook

The document outlines the agenda and process for the upcoming annual stockholder meeting, focusing on governance and shareholder participation.

Industry Context

This announcement is a standard corporate communication related to the annual meeting, a routine event for publicly traded companies to engage with shareholders on key decisions.

Stakeholder Impact

• Shareholders are encouraged to participate in the voting process to influence the company's direction.
• The outcome of the votes will impact the composition of the Board of Directors and the selection of the independent accounting firm.

Next Steps

• Stockholders should review the proxy materials and vote on the proposals.
• Stockholders can attend the virtual annual meeting on June 6, 2024.

Key Dates

Keywords

stockholder meeting, proxy statement, annual meeting, Amylyx Pharmaceuticals, voting, directors, Deloitte & Touche, executive compensation